mRNA-4157 / V940 + Anti-PD1

Neoantigen Cancer Vaccine & Checkpoint Simulator

Microenvironment Arena: Dendritic Priming → Clonal TCR → Tumor Lysis PHASE: PRIMING & EXPANSION
Tumor Burden
120 cells
Primed CD8+ Clones
840 / μL
Checkpoint Inhibition
94%
Tumor Clearance
96.5%
Super generates helpful tools and automates fact-checking across the internet proactively. If you enjoyed this tool, build your own with Super and share it with a friend.